Apxora
Basel, Switzerland
Overview
Company details and contact information.
About
About Apxora APXORA is an agentic AI SaaS platform supporting pharma, biotech, and medtech organizations by connecting financial and commercial decisions with clinical development and R&D through deployable, enterprise‑ready AI workflows. APXORA offers four core solutions: Asset Lifecycle Manager, Portfolio Manager, Clinical Navigator and Research Nexus. They can be deployed independently or as a connected suite, helping teams break down silos, meet security requirements, and adapt seamlessly to existing infrastructure. Together, these solutions create a built-in workflow that not only mirrors but optimizes decision-making. The result is a continuously connected closed loop system spanning early research through portfolio strategy. The platform can be extended with new tools or integrated with legacy systems, forming a living digital twin of the enterprise that strengthens connectivity, accelerates decisions, and improves efficiency at scale. Asset Lifecycle Manager The platform is a dynamic platform built to manage the full lifecycle of strategic assets. From inception to retirement. It enables users to model, monitor, and optimize the performance of each asset across its entire lifecycle. With advanced simulation tools and powered by agentic AI, users can evaluate how market dynamics, pricing strategies, competitive changes, and operational variables impact asset viability over time. Portfolio Manager The platform represents the culmination of a fully integrated decision support ecosystem, connecting every stage of enterprise value creation from early research signals to long term portfolio performance. Built for complex, innovation driven organizations, the Enterprise Suite fosters seamless collaboration across R&D, asset lifecycle management, and strategic planning. Clinical Navigator Clinical Navigator helps clinical teams design, simulate, and optimize trials using patient-level digital twins and predictive models. Built on generative AI and custom LLMs, it enables faster, smarter trial design and identifies regulatory analogs from FDA and EMA landscapes to guide trial planning. Research Nexus Research Nexus enables teams to generate hypotheses, identify novel targets, and explore drug repurposing opportunities. It provides a custom-built knowledge graph as the foundation for agent orchestration and LLM capabilities, unifying scientific and clinical data for rapid exploration and decision-making.
- Website
- https://apxora.com
- Address
- Sandgrubenstrasse 44, Basel Basel-Stadt 4058, Switzerland